Comparative Pharmacology
Head-to-head clinical analysis: CALCIUM CHLORIDE 10 versus CALCIUM CHLORIDE 10 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CALCIUM CHLORIDE 10 versus CALCIUM CHLORIDE 10 IN PLASTIC CONTAINER.
CALCIUM CHLORIDE 10% vs CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calcium chloride dissociates to provide calcium ions, which are essential for myocardial contractility, nerve impulse transmission, and blood coagulation. It antagonizes the cardiotoxic effects of hyperkalemia by stabilizing cardiac cell membrane potential.
Calcium ion is essential for normal cell function, including muscle contraction, nerve transmission, and blood coagulation. It acts as a positive inotrope by increasing myocardial contractility and also corrects hypocalcemia.
IV: 500 mg to 1 g (5-10 mL of 10% solution) administered slowly at a rate not exceeding 0.5-1 mL/min; may be repeated every 1-3 days based on serum calcium levels.
IV: 500 mg to 1 g (5-10 mL of 10% solution) administered slowly at a rate not exceeding 0.5-1 mL/min. May be repeated as needed based on serum calcium levels and clinical response.
None Documented
None Documented
Terminal half-life ~4-6 hours for rapid distribution phase; prolonged in renal impairment (up to 24-48 hours).
2-4 hours in patients with normal renal function; prolonged in renal impairment.
Primarily renal (>80% as ionized calcium); minor fecal elimination (10-20%) via endogenous secretion; negligible biliary excretion.
Primarily renal (80-90% as ionized calcium); minor fecal elimination (<10%).
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement